COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics annonce des résultats positifs complémentaires de l'étude de Phase 2 randomisée Combi-TED de Tedopi® (OSE2101) dans le cancer du poumon non à petites cellules métastatique
29/10/2026
Résultats finaux positifs pour le critère principal et plusieurs critères secondaires présentés par le Pr Federico Cappuzzo, PhD, le 25 octobre 2026 au congrès annuel de l’ European Society for Medical Oncology (ESMO) à [...]
OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
29/10/2026
Final positive readout for primary and several secondary endpoints presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at the Annual Meeting of the European Society for Medical Oncology (ESMO) in Madrid 12- [...]
Cedar Park Packs the Parking Lot for Ally Medical ER’s Official Ribbon Cutting
29/10/2026
Neighbors, families, and community leaders filled the parking lot of the newest Ally Medical ER for an evening of food, games, and celebration CEDAR PARK, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency [...]
Mdxhealth to Release Third Quarter 2026 Financial Results on November 12
29/10/2026
Company to Host Conference Call with Live Q&A, November 12, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – October 29, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics [...]
Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus
29/10/2026
– Phase 2 study will evaluate the safety, pharmacokinetics and antiviral activity of ABI-6250 in participants with chronic HDV infection – – Initial data from the Phase 2 study is expected in the fourth quarter of 2027 [...]
NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine
29/10/2026
Company to issue press release before market open; conference call to follow at 8:30 a.m. ET WILMINGTON, Del., Oct. 29, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, “NRx” or “the Company”), a [...]
MannKind to Report Third Quarter Financial Results and Host Conference Call on November 5, 2026
29/10/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced today that it will report third quarter 2026 financial results after market close on Thursday [...]
BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates
29/10/2026
- $353.2 million in total third quarter revenues, primarily comprised of $253.2 million of U.S. Attruby net product revenue (up approximately $31 million sequentially and $145 million year over year). Loss from [...]
Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook
29/10/2026
Reports third-quarter revenue of $ 1.36 billion, representing 36.7% year-over-year growth Grows health plan membership 31.2% year-over-year to 301,200 members Issues fourth-quarter guidance and lowers full-year 2026 [...]
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
29/10/2026
Solo Pace, Inc. specializes in temporary pacing solutions and systems designed for transcatheter heart valve procedures, including transcatheter aortic valve replacement procedures SOUTH JORDAN, Utah, Oct. 29, 2026 ( [...]
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance
29/10/2026
Financial Highlights† Reported revenue of $416.2 million, up 8.4% Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectively GAAP operating margin of 14.1%, compared to 11.1% in [...]
CapsoVision to Release Third Quarter 2026 Financial Results on November 12, 2026
29/10/2026
SARATOGA, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced [...]
Pliant Therapeutics Announces Presentations at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer
29/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, [...]
Immuneering Reports Third Quarter 2026 Financial Results and Provides Business Updates
29/10/2026
- Phase 2 pancreatic cancer follow-up extended as patients on atebimetinib combinations live longer than projected - - Updated Phase 2 atebimetinib + mGnP pancreatic cancer data (N=55) expected in the first half of 2027 [...]
FOXO TECHNOLOGIES INC. ANNOUNCES AGREEMENTS TO ACQUIRE PREFERRED STOCK CARRYING MAJORITY VOTING POWER IN LUDWIG ENTERPRISES, INC.
29/10/2026
WEST PALM BEACH, FL, Oct. 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc . (OTC: FOXO) (“FOXO” or the “Company”) today announced that it has entered into Stock Purchase Agreements to acquire shares of preferred [...]
Stryker reports third quarter 2026 operating results
29/10/2026
Portage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026: Third Quarter Results Reported net sales increased 7.7% to $6.5 billion Organic net sales [...]
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
29/10/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
29/10/2026
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis Q1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to $2.91 Returned more than $1.0 billion to [...]
Supernus Announces Third Quarter 2026 Financial Results
29/10/2026
Record total revenues of $226.8 million in the third quarter 2026, an 18% increase compared to same period last year. Combined revenues of the Company's four growth products increased to $192.2 million in the third [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum